SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Aquestive Therapeutics Sets November 3 Q3 Results Release and November 4 Call

Aquestive Therapeutics plans to report third-quarter 2026 financial results and business highlights on November 3, followed by a conference call on November 4 at 8:00 a.m. ET.

AQST
SquawkNews Desk

Related stories

Timberland Bancorp Q4 Profit Rises From Prior Quarter, Raises Dividend M impact | EQUITY | Oct 30, 2026, 12:37 AM UTC Semirara Mining Reports Q3 Revenue of 12.64 Billion Pesos M impact | EQUITY | Oct 30, 2026, 12:37 AM UTC FOXO Seeks Voting Control of Ludwig Enterprises With 74.9% Stake FOXO Technologies reported it may beneficially own 74.9% of Ludwig Enterprises’ common stock through a proposed preferred-stock purchase and voting agreements. L impact | EQUITY | Oct 30, 2026, 12:37 AM UTC Ibiden Shares Fall 15% in Tokyo M impact | EQUITY | Oct 30, 2026, 12:34 AM UTC KOSPI Nears Risk of Falling Below 5,700 The report says the KOSPI is at risk of slipping below 5,700, citing Alphabet’s 13% plunge. M impact | EQUITY | Oct 30, 2026, 12:34 AM UTC GS Engineering & Construction Q3 Operating Profit Falls 35.65% The company's Q3 operating profit fell 35.65% year on year. M impact | EQUITY | Oct 30, 2026, 12:33 AM UTC